The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
Abstract
AIMS: The AFFIRM and RACE studies showed that rate control is an acceptable treatment strategy for atrial fibrillation (AF). We examined whether strict rate control offers benefit over more lenient rate control. METHODS AND RESULTS: We compared the outcome of patients enrolled in the rate-control arms of AFFIRM and RACE, using data from patients who met a composite of overlapping inclusion and exclusion criteria. We evaluated 1091 patients, 874 from AFFIRM and 217 from RACE. In AFFIRM, the rate-control strategy aimed for a resting heart rate < or =80 bpm and heart rate during daily activity of < or =110 bpm. In RACE, a more lenient approach was taken: resting heart rate <100 bpm. Primary endpoint was a composite of mortality, cardiovascular hospitalization, and myocardial infarction. Mean heart rate across all follow-up visits for patients in AF was lower in AFFIRM (76.1 vs. 83.4 bpm). Event-free survival for the occurrence of the primary endpoint did not differ (64% in AFFIRM vs. 66% in RACE). Patients with mean heart rates during AF within the AFFIRM (< or =80) or RACE (<100) criteria had a better outcome than patients with heart rates > or =100 (hazard ratios 0.69 and 0.58, respectively, for < or =80 and <100 compared with > or =100 bpm). CONCLUSION: Stringency of the approach to rate control, based on the comparison of the AFFIRM and RACE studies, was not associated with an important difference in clinical events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar results were found in a pooled analysis of the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) and RACE trials (1091 participants), albeit with smaller heart rate differences and without randomization.562”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [562]
Citations
Cites
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Self-citationThe AFFIRM Investigators (2004) · Circulation · doi:10.1161/01.cir.0000121736.16643.11 · Cited by 1,202
Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation
Clark, D. M., Plumb, V. J., Epstein, A. E., & Kay, G. N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00254-4 · Cited by 610
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
Olshansky, B., Rosenfeld, L. E., Warner, A. L., Solomon, A. J., O’Neill, G., Sharma, A. D., Platia, E. V., Feld, G. K., Akiyama, T., Brodsky, M. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.032 · Cited by 599
Self-citationLechat, P. P., Hulot, J., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 526
Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
Packer, D. L., Bardy, G. H., WORLEY, S. J., Stafford‐Smith, M., Cobb, F. R., Coleman, R. E., Gallagher, J. J., & German, L. D. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90836-2 · Cited by 524
Grogan, M. A., Smith, H. C., Gersh, B. J., & Wood, D. L. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90705-4 · Cited by 519
Effect of an irregular ventricular rhythm on cardiac output
Daoud, E. G., Weiss, R., Bahu, M., Knight, B. P., Bogun, F. M., Goyal, R., Harvey, M. N., Strickberger, S. A., Man, K. C., & Morady, F. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89297-1 · Cited by 361
Atrial Fibrillation Follow-Up Investigation of Rhythm Management—The AFFIRM Study Design
(1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00082-9 · Cited by 277
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,594
Self-citation2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062
Lenient versus strict rate control in patients with atrial fibrillation
Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033
Self-citationAtrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
Ball, J., Carrington, M. J., McMurray, J. J. V., & Stewart, S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.093 · Cited by 652
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P. P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González‐Juanatey, J. R., Harjola, V., Jankowska, E. A., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0141 · Cited by 458
Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409
Self-citation2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4083 · Cited by 553
Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda
Rohde, L. E. P., Montera, M. W., Bocchi, E. A., Clausell, N., de Albuquerque, D. C., Rassi, S., Colafranceschi, A. S., Freitas, A. F., Ferraz, A. S., Biolo, A., et al. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180190 · Cited by 492
Management of atrial fibrillation
Lip, G. Y., & Tse, H.-F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61300-2 · Cited by 229
Dan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 247
2024 Clinical practice guidelines for Chronic heart failure
Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 251
Rate control in atrial fibrillation
Gelder, I. C. V., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 212
Self-citationRate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review
Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1467 · Cited by 178
Camm, A. J., BREITHARDT, G. E., Crijns, H. J. G. M., Dorian, P., Kowey, P. R., Heuzey, J. L., Merioua, I., Pedrazzini, L., Prystowsky, E. N., Schwartz, P. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.034 · Cited by 177
Self-citationIs Heart Rate Important for Patients With Heart Failure in Atrial Fibrillation?
Cullington, D., Goode, K. M., Zhang, J., Cleland, J. G. F., & Clark, A. L. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.01.005 · Cited by 138
Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138
Steg, P. G., Alam, S., Chiang, C., Gamra, H., Goethals, M., Inoue, H., Krapf, L., Lewalter, T., Merioua, I., Murín, J., et al. (2011) · Heart · doi:10.1136/heartjnl-2011-300550 · Cited by 137
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Treatment of Atrial Fibrillation
Prystowsky, E. N., Padanilam, B. J., & Fogel, R. I. (2015) · JAMA · doi:10.1001/jama.2015.7505 · Cited by 117
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 119
Ulimoen, S. R., Enger, S., Carlson, J., Platonov, P. G., Pripp, A. H., Abdelnoor, M., Arnesen, H., Gjesdal, K., & Tveit, A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.020 · Cited by 113
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4083 · Cited by 88
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G. J., Dibb, K. M., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 82
Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
Mulder, B. A., van Veldhuisen, D. J., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Rienstra, M., van den Berg, M. P., & Gelder, I. C. V. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.06.007 · Cited by 69
Self-citationBui, A. L., Grau‐Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., & Fonarow, G. C. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.007 · Cited by 68
Steinberg, B. A., Kim, S., Thomas, L. E., Fonarow, G. C., Gersh, B. J., Holmqvist, F., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Naccarelli, G. V., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002031 · Cited by 65
Groenveld, H. F., Tijssen, J. G. P., Crijns, H. J. G. M., van den Berg, M. P., Hillege, H. L., Alings, M., van Veldhuisen, D. J., & Gelder, I. C. V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.038 · Cited by 60
Self-citationCamm, A. J., Savelieva, I., Ho, S. Y., Lindsay, B. D., Nattel, S., & Shinagawa, K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00044-2 · Cited by 60
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 109
Rate Control in Atrial Fibrillation
Heist, E. K., MANSOUR, M. C., & Ruskin, J. N. (2011) · Circulation · doi:10.1161/circulationaha.111.019919 · Cited by 53
Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.030 · Cited by 50
Self-citationKotecha, D., Calvert, M., Deeks, J. J., GRIFFITH, M. J., Kirchhof, P. F., Lip, G. Y. H., Mehta, S. P., Slinn, G., Stanbury, M., Steeds, R. P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015099 · Cited by 48
Treatment of atrial fibrillation
Bajpai, A., Savelieva, I., & Camm, A. J. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn046 · Cited by 42
Tachycardia-mediated cardiomyopathy: Recognition and management
Gopinathannair, R., Sullivan, R. M., & Olshansky, B. (2009) · Current Heart Failure Reports · doi:10.1007/s11897-009-0035-3 · Cited by 42
Self-citationRetrospective Evaluation of the Effect of Heart Rate on Survival in Dogs with Atrial Fibrillation
Pedro, B., Dukes‐McEwan, J., Oyama, M. A., Kraus, M. S., & Gelzer, A. R. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14896 · Cited by 41
Kao, D. P., Davis, G. W., Aleong, R. G., O’Connor, C. M., Fiuzat, M., Carson, P. E., Anand, I. S., Plehn, J. F., Gottlieb, S. S., Silver, M. A., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs181 · Cited by 39
Novel Perspectives on Arrhythmia-Induced Cardiomyopathy
Rocca, D. G. D., Santini, L., Forleo, G. B., Sanniti, A., Prete, A. D., Lavalle, C., Biase, L. D., Natale, A., & Romeo, F. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000040 · Cited by 31
Does intensity of rate control influence outcome in persistent atrial fibrillation?
Groenveld, H. F., Crijns, H. J. G. M., Rienstra, M., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.09.007 · Cited by 29
Self-citationHindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Rienzo, F. D., Gabdoulline, R. R., Wade, R. C., Sola, M., & Menziani, M. C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3181-5 · Cited by 27
Atrial fibrillation: better symptom control with rate and rhythm management
Gupta, D., Rienstra, M., Gelder, I. C. V., & Fauchier, L. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100801 · Cited by 31
Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice
Eagle, K. A., Cannom, D. S., & Garcia, D. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.016 · Cited by 24
Medical treatment of atrial fibrillation
Camm, A. J., Camm, C. F., & Savelieva, I. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834f23e1 · Cited by 22
Ventricular rate in atrial fibrillation and the risk of heart failure and death
Westergaard, L. M., Alhakak, A., Rørth, R., Fosbøl, E. L., Kristensen, S. L., Svendsen, J. H., Graff, C., Nielsen, J. B., Gislason, G., Køber, L., et al. (2023) · EP Europace · doi:10.1093/europace/euad088 · Cited by 22
Atrial fibrillation: the rate versus rhythm management controversy
Aj, C., & Savelieva, I. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.s03 · Cited by 22
Atrial fibrillation: insights from clinical trials and novel treatment options
Blaauw, Y., & Crijns, H. J. G. M. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01885.x · Cited by 22
Self-citationManolis, A. S., Manolis, T. A., Manolis, A. S., & Melita, H. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10221-1 · Cited by 21
Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation
Wyse, D. G. (2009) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9329-8 · Cited by 21
Self-citationHendrikx, J., Ruijs, L. S., Cox, L. G. E., Lemmens, P. M. C., Schuijers, E. G., & Goris, A. H. C. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6893 · Cited by 19
Therapeutic Considerations in Applying Rate Control Therapy for Atrial Fibrillation
Wyse, D. G. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31816d5f49 · Cited by 20
Self-citationMulder, B. A., Damman, K., van Veldhuisen, D. J., Gelder, I. C. V., & Rienstra, M. (2017) · Clinical Cardiology · doi:10.1002/clc.22725 · Cited by 20
Antiarrhythmic Drugs and Strategies
Opie, L. H., Dimarco, J., & Gersh, B. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-6158-8.50013-7 · Cited by 16
Savelieva, I., Kirchhof, P. F., Danchin, N., de Graeff, P. A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur181 · Cited by 15
Cornelis, J., & MYERS, J. N. (2018) · Cardiac failure review · doi:10.15420/cfr.2018.19.2 · Cited by 15
Antiarrhythmic drugs and strategies
Nattel, S., Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00017-x · Cited by 15
Lenient Versus Strict Rate Control in Atrial Fibrillation
Wyse, D. G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.028 · Cited by 15
Self-citationOutcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias
Steinberg, B. A., Schulte, P. J., Hofmann, P., Ersbøll, M. K., Alexander, J. H., Broderick-Forsgren, K., Anstrom, K. J., Granger, C. B., Piccini, J. P., Velazquez, E. J., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.02.030 · Cited by 14
Tse, H., Wong, K.-K., Siu, C., Tang, M.-O., Tsang, V., Ho, W. Y., & Lau, C. (2009) · EP Europace · doi:10.1093/europace/eup087 · Cited by 14
Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
Moschovitis, G., Johnson, L., Blum, S., Aeschbacher, S., Perna, M. L. D., Pagnamenta, A., Melchiorre, P. A. M., Benz, A. P., Kobza, R., Valentino, M. D., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001606 · Cited by 13
Influence of Heart Rate on Quality of Life in Patients With Chronic Atrial Fibrillation
Jaber, J., Cirenza, C., Jaber, J., Amaral, A., de Sousa, J. M. A., Filho, J. A. O., & de Paola, Â. A. V. (2010) · Clinical Cardiology · doi:10.1002/clc.20528 · Cited by 13
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Михайловна, Г. Е., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-3-6-76 · Cited by 12
Kim, M., Lin, J., Hussein, M. A., & Battleman, D. S. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903368716 · Cited by 12
Song, S., Ko, J. S., Lee, H. A., Choi, E., Cha, M., Kim, T., Park, J., Lee, J.-M., Kang, K., Shim, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.787869 · Cited by 12
The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology
Peuskens, J., Tanghøj, P., & Mittoux, A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1594 · Cited by 12
Incremental Changes in QRS Duration Predict Mortality in Patients with Atrial Fibrillation
Lin, Y., Liu, Y., & Chu, C.-C. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02508.x · Cited by 11
Hersi, A. S., Alsheikh-Ali, A. A. A., Zubaid, M., & Suwaidi, J. M. S. A. (2012) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2012.08.001 · Cited by 10
Suzuki, S., Motoki, H., Kanzaki, Y., Maruyama, T., Hashizume, N., Kozuka, A., Yahikozawa, K., & Kuwahara, K. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01573-5 · Cited by 11
Waldo, A. L. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.006 · Cited by 10
Ventricular Rate Control of Atrial Fibrillation in Heart Failure
Rienstra, M., & Gelder, I. C. V. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.004 · Cited by 9
Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome
Boriani, G., Padeletti, L., Santini, M., Gulizia, M. M., Orazi, S., Botto, G., Capucci, A., Biffi, M., Martignani, C., Ricci, R. P., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.001 · Cited by 9
Pharmacological Management of Atrial Fibrillation: One, None, One Hundred Thousand
Lucà, F., Meir, M. L., Rao, C. M., Parise, O., Vasquez, L., Carella, R., Lorusso, R., Daniela, B., Maessen, J. G., Gensini, G. F., et al. (2011) · Cardiology Research and Practice · doi:10.4061/2011/874802 · Cited by 9
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017
Kanagaratnam, L. B., Kowey, P. R., & Whalley, D. W. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.134 · Cited by 10
Update on medical management of atrial fibrillation in the modern era
Gopinathannair, R., Sullivan, R. M., & Olshansky, B. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.02.013 · Cited by 8
Self-citationTereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Rimskaya, E. M., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-2-6-76 · Cited by 8
Frausing, M. H. J. P., van de Lande, M. E., Maass, A. H., Nguyen, B., Hemels, M. E. W., Tieleman, R. G., Koldenhof, T., Melis, M. D., Linz, D., Schotten, U., et al. (2023) · Heart · doi:10.1136/heartjnl-2022-322253 · Cited by 8
Self-citationSchryver, N. D., Scavée, C., Marchandise, S., Pasquet, A., de Meester, C., & de Waroux, J. L. P. (2014) · EP Europace · doi:10.1093/europace/euu033 · Cited by 8
Medical, interventional, and surgical treatment strategies for atrial fibrillation
Willems, S., Gunawardene, M., Eickholt, C., Hartmann, J., Schmoeckel, M., & Schäffer, B. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0002 · Cited by 9
Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8
Antiarrhythmic Treatment in Heart Failure
Könemann, H., Güler-Eren, S., Ellermann, C., Frommeyer, G., & Eckardt, L. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-023-00642-w · Cited by 8
Luo, X., Xiong, Q., Xu, J., Hong, K., Peng, Q., Li, J., Cheng, X., Lip, G. Y. H., & Su, H. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.048 · Cited by 7
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications
Nelson, J. A., Gue, Y. X., Christensen, J. M., Lip, G. Y. H., & Ramakrishna, H. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.05.011 · Cited by 8
Koniari, I. C., Artopoulou, E., Velissaris, D., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.05.003 · Cited by 8
Bozkurt, S. (2020) · Applied Sciences · doi:10.3390/app10030876 · Cited by 7
Atrial fibrillation and flutter – the state of the art. Part 2
Janion−Sadowska, A., Turek, Ł., Dudek, A., Andrychowski, J., & Sadowski, M. (2021) · Medical Studies · doi:10.5114/ms.2021.109530 · Cited by 7
Wan, H., Yang, Y., Zhu, J., Shao, X., Wang, J., Huang, B., & Zhang, H. (2015) · Medicine · doi:10.1097/md.0000000000000920 · Cited by 7
Atrial fibrillation: Yesterday, today, and tomorrow
Кanorskiy, S. G., Galenko-Yaroshevsky, P. A., Алексеенко, С. Н., & Sp, G. (2025) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2025-32-3-107-120 · Cited by 7
Ermert, L., Kreimer, F., Quast, D. R., Pflaumbaum, A., Mügge, A., & Gotzmann, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.940060 · Cited by 6
Lai, Y., Xu, X., Zhang, S., Huang, R., Huang, Y., Zhong, X., Xiong, Z., Lin, Y., Zhou, H., Guo, Y., et al. (2024) · Global Heart · doi:10.5334/gh.1251 · Cited by 6
Update on anti-coagulation in atrial fibrillation
Kreuzer, J. (2011) · QJM · doi:10.1093/qjmed/hcr107 · Cited by 6
Hudoyo, A. W., Fukuda, H., Imazu, M., Shindo, K., Fu, H., Iwata, Y., Ito, S., & Kitakaze, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0289-4 · Cited by 6
Metadata
- Authors
- Van Gelder, I. C., Wyse, D. G., Chandler, M. L., Cooper, H. A., Olshansky, B., Hagens, V. E., & Crijns, H. J. G. M.
- Affiliations
- Libin Cardiovascular Institute of Alberta (CA)
- MedStar Washington Hospital Center (US)
- University of Iowa (US)
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Venue
- EP Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-14
- Volume
- 8
- Issue
- 11
- Pages
- 935-942
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2117915052
- Cited by
- 165
- References
- 17
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 13 · 2020: 12 · 2019: 3 · 2018: 7 · 2017: 13 · 2016: 8 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 7
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- EP Europace (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Institutes of Health (n01hc055139-000)
- National Heart, Lung, and Blood Institute (N01-HC-55139)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- atrial fibrillation, rate control, resting heart rate, target heart rate, event-free survival, mortality, cardiovascular hospitalization, myocardial infarction, AFFIRM trial, pooled analysis
- MeSH terms
- Aged, Atrial Fibrillation, Cardiac Pacing, Artificial, Clinical Trials as Topic, Female, Heart Rate, Humans, International Cooperation, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Survival Rate, Proportional Hazards Models, Survival Analysis, Treatment Outcome, Outcome Assessment, Health Care, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review